Whether public or private, large infrastructure projects involve complex risk and resource management. Project owners must first identify, describe and mitigate design, construction, financing and ...

LAS VEGAS, Feb. 26, 2024 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an artificial intelligence technology (AI) company specializing in creating and developing ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., and PARIS, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners (MOLN) AG (SIX: MOLN; NASDAQ: MOLN), a ...

Vasomune Therapeutics Inc., and AnGes Inc., are pleased to announce that they have entered into an agreement to expand the research indications for the Tie2 receptor agonist Pegevongitide (AV-001) ...

AT278 (500U/mL) is the only ultra-concentrated and ultra-rapid acting insulin in development designed to enable the next generation of longer-wear and miniaturised automated insulin delivery (AID) ...

Diriyah Company And Midad Development And Real Estate Investment Company Announce Joint Development Agreement For Four ...

Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - January 21, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

HORGEN, Switzerland and TOKYO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Numab Therapeutics AG(“Numab”), a biotechnology company advancing a proprietary pipeline of multispecific antibodies in immunology and ...

DIRIYAH, Saudi Arabia – Diriyah Company has announced a new joint development agreement with Midad Development and Real ...